Other
Placcebo
Placcebo is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
1
33%
Ph not_applicable
2
67%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Early Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
Enrolling by invitation1
unknown1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1
Trials by Phase
Early Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
enrolling_by_invitation133%
unknown133%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
enrolling_by_invitationnot_applicable
Individual Differences in Acute Response to Experimental Inflammation: Microcirculatory Changes and Psychological Predictors
NCT06618716
completednot_applicable
Effect of Lavender Versus Primrose Oil on Menopause Symptom
NCT05988242
unknownearly_phase_1
Glutamine and Traumatic Brain Injury
NCT05569993
Clinical Trials (3)
Showing 3 of 3 trials
NCT06618716Not Applicable
Individual Differences in Acute Response to Experimental Inflammation: Microcirculatory Changes and Psychological Predictors
NCT05988242Not Applicable
Effect of Lavender Versus Primrose Oil on Menopause Symptom
NCT05569993Early Phase 1
Glutamine and Traumatic Brain Injury
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3